Scientists have evolved from well off dabblers and the intellectually curious to sometimes well paid professionals to grubbing entrepreneurs and corporations.
MicroRNAs Make Big Impression in Disease After Disease
"Many microRNAs overlap among a number of cancers, which makes commercializing them less daunting. Recently, Asuragen closed on a second round of funding, garnering $18.5 million."
No comments:
Post a Comment